BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28084343)

  • 21. Oncogenic mutations in GNAQ occur early in uveal melanoma.
    Onken MD; Worley LA; Long MD; Duan S; Council ML; Bowcock AM; Harbour JW
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5230-4. PubMed ID: 18719078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers.
    Parish AJ; Nguyen V; Goodman AM; Murugesan K; Frampton GM; Kurzrock R
    Cancer; 2018 Oct; 124(20):4080-4089. PubMed ID: 30204251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations.
    Boru G; Cebulla CM; Sample KM; Massengill JB; Davidorf FH; Abdel-Rahman MH
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2474-2480. PubMed ID: 31173078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombotic Hemangioma With Organizing/Anastomosing Features: Expanding the Spectrum of GNA-mutated Hemangiomas With a Predilection for the Skin of the Lower Abdominal Regions.
    Liau JY; Lee JC; Tsai JH; Chen CC; Wang YH; Chung YC
    Am J Surg Pathol; 2020 Feb; 44(2):255-262. PubMed ID: 31633489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uveal Melanoma:
    Psinakis F; Katseli A; Koutsandrea C; Frangia K; Florentin L; Apostolopoulou D; Dimakopoulou K; Papakonstantinou D; Georgopoulou E; Brouzas D
    Anticancer Res; 2017 Oct; 37(10):5719-5726. PubMed ID: 28982892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital hepatic hemangiomas: Clinical, histologic, and genetic correlation.
    Triana P; Rodríguez-Laguna L; Giacaman A; Salinas-Sanz JA; Martín-Santiago A; López-Santamaría M; Palacios E; Beato MJ; Martinez-González V; López-Gutierrez JC
    J Pediatr Surg; 2020 Oct; 55(10):2170-2176. PubMed ID: 32115227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan.
    Ominato J; Fukuchi T; Sato A; Yamaguchi N; Kobayashi K; Cho H; Oyama T; Ajioka Y
    Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):658-663. PubMed ID: 28248732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms.
    Küsters-Vandevelde HV; van Engen-van Grunsven IA; Coupland SE; Lake SL; Rijntjes J; Pfundt R; Küsters B; Wesseling P; Blokx WA; Groenen PJ
    Pathol Oncol Res; 2015 Apr; 21(2):439-47. PubMed ID: 25315378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic Profiling of Metastatic Uveal Melanoma Shows Frequent Coexisting BAP1 or SF3B1 and GNAQ/GNA11 Mutations and Correlation With Prognosis.
    Isaacson AL; Sompallae RR; Guseva NV; Bellizzi AM; Bossler AD; Ma D
    Am J Clin Pathol; 2022 Aug; 158(2):177-186. PubMed ID: 35212356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi.
    Bender RP; McGinniss MJ; Esmay P; Velazquez EF; Reimann JD
    Mod Pathol; 2013 Oct; 26(10):1320-8. PubMed ID: 23599145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis.
    Küsters-Vandevelde HV; van Engen-van Grunsven IA; Küsters B; van Dijk MR; Groenen PJ; Wesseling P; Blokx WA
    Acta Neuropathol; 2010 Dec; 120(6):755-64. PubMed ID: 20865267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese.
    Xu X; Wei WB; Li B; Gao F; Zhang Z; Jonas JB
    PLoS One; 2014; 9(10):e109699. PubMed ID: 25280020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational analysis for GNAQ mutations: New insights on the molecular etiology of Sturge-Weber syndrome.
    Martins L; Giovani PA; Rebouças PD; Brasil DM; Haiter Neto F; Coletta RD; Machado RA; Puppin-Rontani RM; Nociti FH; Kantovitz KR
    J Mol Graph Model; 2017 Sep; 76():429-440. PubMed ID: 28779688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of
    Zhao Q; Chen YY; Hou C; Zeng SX; Zhang YH; Zhang JJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 51(4):521-525. PubMed ID: 32691561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma.
    Dratviman-Storobinsky O; Cohen Y; Frenkel S; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6180-2. PubMed ID: 20631239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis.
    Sheng X; Kong Y; Li Y; Zhang Q; Si L; Cui C; Chi Z; Tang B; Mao L; Lian B; Wang X; Yan X; Li S; Dai J; Guo J
    Eur J Cancer; 2016 Sep; 65():156-63. PubMed ID: 27498141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SF3B1 and BAP1 mutations in blue nevus-like melanoma.
    Griewank KG; Müller H; Jackett LA; Emberger M; Möller I; van de Nes JA; Zimmer L; Livingstone E; Wiesner T; Scholz SL; Cosgarea I; Sucker A; Schimming T; Hillen U; Schilling B; Paschen A; Reis H; Mentzel T; Kutzner H; Rütten A; Murali R; Scolyer RA; Schadendorf D
    Mod Pathol; 2017 Jul; 30(7):928-939. PubMed ID: 28409567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
    Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
    J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations.
    Piaggio F; Croce M; Reggiani F; Monti P; Bernardi C; Ambrosio M; Banelli B; Dogrusöz M; Jockers R; Bordo D; Puzone R; Viaggi S; Coviello D; Lanza FB; Bartolucci M; Petretto A; Mosci C; Gangemi R; van der Velden PA; Jager MJ; Pfeffer U; Amaro A
    Eur J Cancer; 2022 Jul; 170():27-41. PubMed ID: 35580369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.